Sofie Bliddal

Sofie Bliddal

Auto-generated profile, based on publicly available information

Sofie Bliddal

Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2017 in F1000Research
Verified
Journal Article
Open access
PDF file
SBSofie Bliddal
Sofie Bliddal
CNClaus Henrik Nielsen
Claus Henrik Nielsen
UFUlla Feldt-Rasmussen
Ulla Feldt-Rasmussen
Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is referred to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries unravelling the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity.

21 July 2022 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
JOJoris Osinga
Joris Osinga
ADArash Derakhshan
Arash Derakhshan
GPGlenn E Palomaki
Glenn E Palomaki
GAGhalia Ashoor
Ghalia Ashoor
TMTuija Männistö
Tuija Männistö
TKTim I M Korevaar
Tim I M Korevaar
Context: Interpretation of thyroid function tests during pregnancy is limited by the generalizability of reference intervals between cohorts due to inconsistent methodology. Objective: (1) To provide an overview of published reference intervals for thyrotropin (TSH) and free thyroxine (FT4) in pregnancy, (2) to assess the consequences of common methodological between-study differences by combining raw data from different cohorts. Methods: (1) Ovid MEDLINE, EMBASE, and Web of Science were searched until December 12, 2021. Studies were assessed in duplicate. (2) The individual participant data (IPD) meta-analysis was performed in participating cohorts in the Consortium on Thyroid and Pregnancy. Results: (1) Large between-study methodological differences were identified, 11 of 102 included studies were in accordance with current guidelines; (2) 22 cohorts involving 63 198 participants were included in the meta-analysis. Not excluding thyroid peroxidase antibody–positive participants led to a rise in the upper limits of TSH in all cohorts, especially in the first (mean +17.4%; range +1.6 to +30.3%) and second trimester (mean +9.8%; range +0.6 to +32.3%). The use of the 95th percentile led to considerable changes in upper limits, varying from –10.8% to –21.8% for TSH and –1.2% to –13.2% for FT4. All other additional exclusion criteria changed reference interval cut-offs by a maximum of 3.5%. Applying these findings to the 102 studies included in the systematic review, 48 studies could be used in a clinical setting. Conclusion: We provide an overview of clinically relevant reference intervals for TSH and FT4 in pregnancy. The results of the meta-analysis indicate that future studies can adopt a simplified study setup without additional exclusion criteria.

15 March 2011 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
SBSofie Bliddal
Sofie Bliddal
ÅRÅse Krogh Rasmussen
Åse Krogh Rasmussen
KSKarin Sundberg
Karin Sundberg
VBVibeke Brocks
Vibeke Brocks
UFUlla Feldt-Rasmussen
Ulla Feldt-Rasmussen

1 February 2014 in European Journal of Endocrinology
Verified
Journal Article
Closed access
SBSofie Bliddal
Sofie Bliddal
UFUlla Feldt-Rasmussen
Ulla Feldt-Rasmussen
MBMalene Boas
Malene Boas
JFJens Faber
Jens Faber
AJAnders Juul
Anders Juul
DPDorthe Hansen Precht
Dorthe Hansen Precht
Objectives: Correct interpretation of thyroid status during pregnancy is vital to secure fetal development. Pregnancy-related changes in maternal thyroid status necessitate the use of gestational age-specific reference ranges. In this study, we investigated between-laboratory reproducibility of thyroid reference ranges in pregnant women.Design: Comparison of two longitudinal prospective cohort studies including 255 (cohort 1) and 101 (cohort 2) healthy antibody-negative Danish pregnant women attending prenatal care at Copenhagen University Hospital.Methods: Different immunoassays were used to measure thyroid hormone levels in the two cohorts. Thyroid hormone reference ranges were established for every 5 weeks of gestation. Differences between cohorts were explored through mixed-model repeated measures regression analyses. By applying reference ranges from one cohort to the other, the proportion of women who would be misclassified by doing so was investigated.Results: TSH increased and free thyroxine (FT4) decreased as pregnancy progressed. Results indicated highly significant differences between cohorts in free triiodothyronine (F=21.3, P<0.001) and FT4 (F=941, P<0.001). TSH levels were comparable (P=0.09). Up to 90.3% of the women had FT4 levels outside their laboratory's nonpregnant reference range, and up to 100% outside the other cohort's gestational-age-specific reference ranges. Z-score-based reference ranges markedly improved comparison between cohorts.Conclusion: Even in the same region, the use of gestational-age-specific reference ranges from different laboratories led to misclassification. Up to 100% of maternal FT4 levels fell outside the other cohort's reference range despite similar TSH levels. In clinical practice, thyroid testing of pregnant women without adding method specificity to gestational age-dependent reference ranges will compromise patient safety.

1 July 2022 in Thyroid®
Verified
Journal Article
Closed access
SBSofie Bliddal
Sofie Bliddal
ADArash Derakhshan
Arash Derakhshan
YXYi Xiao
Yi Xiao
LCLiang-Miao Chen
Liang-Miao Chen
TMTuija Männistö
Tuija Männistö
UFUlla Feldt-Rasmussen
Ulla Feldt-Rasmussen
Objectives: Thyroid autoimmunity is common in pregnant women and associated with thyroid dysfunction and adverse obstetric outcomes. Most studies focus on thyroid peroxidase autoantibodies (TPOAbs) assessed by negative-positive dichotomy and rarely take into account thyroglobulin autoantibodies (TgAbs). This study aimed at determining the association of TPOAbs and TgAbs, respectively and interdependently, with maternal thyroid function. Methods: This was a meta-analysis of individual participant cross-sectional data from 20 cohorts in the Consortium on Thyroid and Pregnancy. Women with multiple pregnancy, pregnancy by assisted reproductive technology, history of thyroid disease or use of thyroid interfering medication were excluded. Associations of (log2) TPOAbs and TgAbs (with/without mutual adjustment) with cohort-specific z-scores of (log2) thyroid stimulating hormone (TSH), free triiodothyronine (FT3), total triiodothyronine (TT3), free thyroxine (FT4), total thyroxine (TT4) or T3:T4 ratio were evaluated in a linear mixed model. Results: In total, 51,138 women participated (51,094 had TPOAb-data and 27,874 TgAb-data). Isolated TPOAb-positivity was present in 4.1% (95% confidence interval(CI):3.0-5.2), isolated TgAb-positivity in 4.8% (95%CI:2.9-6.6), and positivity for both antibodies in 4.7% (95%CI:3.1-6.3). Compared to antibody-negative women, TSH was higher in women with isolated TPOAb-positivity (z-score increment 0.40, 95% confidence interval(CI):0.16-0.64) and TgAb-positivity (0.21,95%CI:0.10-0.32), but highest in those positive for both antibodies (0.54,95%CI:0.36-0.71). There was a dose-response effect of higher TPOAb and TgAb concentrations with higher TSH (TSH z-score increment for TPOAbs 0.12,95%CI:0.09-0.15, TgAbs 0.08,95%CI:0.02-0.15)). When adjusting analyses for the other antibody, only the association of TPOAbs remained statistically significant. Higher TPOAb concentration was associated with lower FT4 (p<0.001) and higher T3:T4 ratio (0.09, 95%CI:0.03-0.14), however, the association with FT4 was not significant when adjusting for TgAbs (p=0.16). Conclusions: This individual participant data meta-analysis demonstrated an increase in TSH with isolated TPOAb-positivity and TgAb-positivity, respectively, which was amplified for individuals positive for both antibodies. There was a dose-dependent association of TPOAbs, but not TgAbs, with TSH when adjusting for the other antibody. This supports current practice of using TPOAbs in initial laboratory testing of pregnant women suspected of autoimmune thyroid disease. However, studies on the differences between TPOAb- and TgAb-positive women are needed to fully understand the spectrum of phenotypes.

1 January 2011 in Journal of Thyroid Research
Verified
Journal Article
Open access
PDF file
MHMarie-Louise Hartoft-Nielsen
Marie-Louise Hartoft-Nielsen
MBMalene Boas
Malene Boas
SBSofie Bliddal
Sofie Bliddal
ÅRÅase Krogh Rasmussen
Åase Krogh Rasmussen
KMKatharina M. Main
Katharina M. Main
UFUlla Feldt-Rasmussen
Ulla Feldt-Rasmussen
Maternal euthyroidism during pregnancy is crucial for normal development and, in particular, neurodevelopment of the foetus. Up to 3.5 percent of pregnant women suffer from hypothyroidism. Industrial use of various chemicals—endocrine disrupting chemicals (EDCs)—has been shown to cause almost constant exposure of humans with possible harmful influence on health and hormone regulation. EDCs may affect thyroid hormone homeostasis by different mechanisms, and though the effect of each chemical seems scarce, the added effects may cause inappropriate consequences on, for example, foetal neurodevelopment. This paper focuses on thyroid hormone influence on foetal development in relation to the chemicals suspected of thyroid disrupting properties with possible interactions with maternal thyroid homeostasis. Knowledge of the effects is expected to impact the general debate on the use of these chemicals. However, more studies are needed to elucidate the issue, since human studies are scarce.